Twenty-Eight Health Medical Leadership and Credentials: An Independent Review

What Is Twenty-Eight Health and Who Runs Its Clinical Operations?

Twenty-Eight Health is a direct-to-consumer telehealth company that launched in 2019 with a stated focus on expanding contraceptive access to underserved populations, particularly women on Medicaid. The company offers asynchronous consultations for birth control, emergency contraception, and related reproductive health services.

The company does not, as of this writing, publish a named Chief Medical Officer or Medical Director on its public-facing website. That is an unusual gap for a YMYL telehealth service. Patients who want to confirm the clinical leadership by name should contact Twenty-Eight Health's support team directly or search the Delaware Division of Corporations and New York State licensing databases, where the entity is registered.

Founding Context and Mission Statement

Twenty-Eight Health's publicly stated mission centers on equity in reproductive healthcare access. The platform has received funding from venture investors focused on women's health. However, funding rounds and mission statements are not substitutes for publicly verifiable medical governance documents, and patients should treat them as background context only.

What the Company Does Publish

The company does state on its website that all prescriptions are issued by licensed healthcare providers. It does not publish a provider directory with individual NPI numbers. Patients can request the name and license number of their specific prescriber after a consultation, which is consistent with state-level informed consent requirements in most jurisdictions.

Prescriber Licensing: How to Verify It Independently

Every clinician who issues a prescription through Twenty-Eight Health must hold a valid license in the patient's state of residence. That is not optional. It is a federal and state legal requirement.

The National Plan and Provider Enumeration System (NPPES), maintained by the Centers for Medicare and Medicaid Services, allows anyone to search a provider's National Provider Identifier (NPI) at https://nppes.cms.hhs.gov. Patients who receive a prescription should ask for the prescriber's full name and NPI, then verify active licensure in their state.

State Medical Board Verification

Each state maintains its own medical board licensing database. The Federation of State Medical Boards operates a consolidated lookup tool at https://www.fsmb.org/physician-regulatory-news/docinfo/ that covers physicians. Nursing boards maintain separate registries. Any active disciplinary actions, license suspensions, or malpractice settlements that resulted in board action will appear there.

NP and PA Prescribing Authority

Many telehealth platforms, including those in reproductive health, use nurse practitioners (NPs) and physician assistants (PAs) as their primary prescribers. Both can legally prescribe hormonal contraceptives in all 50 states, though the degree of required physician oversight varies by state. California, Oregon, and New York allow NPs to practice fully independently. States such as Florida and Texas require a collaborative practice agreement with a supervising physician.

If a patient in a state with physician oversight requirements wants to confirm that Twenty-Eight Health's NPs are operating under a valid collaborative agreement, they can file a public records request with the relevant state medical or nursing board. This is a standard due-diligence step for any telehealth platform.

Is Twenty-Eight Health a Legitimate Service?

Yes, with important caveats. The platform appears to operate within legal frameworks for telehealth prescribing, but several transparency gaps warrant patient attention.

Legal Operating Status

Twenty-Eight Health is incorporated in the United States and operates subject to the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which governs online prescribing of controlled substances. Hormonal contraceptives are not controlled substances, so the stricter in-person evaluation requirement of the Ryan Haight Act does not apply to the core contraceptive prescriptions Twenty-Eight Health issues. The FDA's guidance on internet pharmacy compliance is available at https://www.fda.gov/drugs/human-drug-compounding/telehealth-and-prescribing-controlled-substances.

LegitScript and Pharmacy Partners

LegitScript is the leading third-party certification body for online pharmacies and telehealth platforms (https://legitscript.com). As of this review, Twenty-Eight Health does not appear in LegitScript's certified telehealth platform registry. That absence is not proof of wrongdoing. LegitScript certification is voluntary, and many legitimate services have not sought it. The absence does, however, mean patients cannot rely on LegitScript's independent vetting as a proxy for quality assurance here.

Twenty-Eight Health dispenses through pharmacy partners rather than an in-house dispensing facility. Patients receive prescriptions filled by licensed retail or mail-order pharmacies. Any pharmacy that fills a Twenty-Eight Health prescription must itself hold a valid state pharmacy license, which can be verified through the state board of pharmacy.

BBB Record

The Better Business Bureau (BBB) does not list Twenty-Eight Health as an accredited business as of this review. The BBB profile shows limited complaint volume, which may reflect the platform's relatively small subscriber base rather than a clean record. Patients should check the current BBB profile at https://www.bbb.org because records change. BBB ratings are one data point, not a definitive quality signal.

The HealthRX Telehealth Credential Verification Framework (Reproductive Health Platforms)

Before using any telehealth reproductive health service, apply this five-point check:

1. Named medical director. Is a licensed physician named and their board certification verifiable through ABMS (https://www.certificationmatters.org)?
2. Provider NPI lookup. After your first consultation, search your prescriber's NPI in NPPES to confirm active status and correct specialty.
3. State license in good standing. Cross-check the prescriber's name against your state medical or nursing board's public disciplinary database.
4. Pharmacy licensing. Confirm the dispensing pharmacy holds a current license in your state via the National Association of Boards of Pharmacy's Verified Internet Pharmacy Practice Sites (VIPPS) program at https://nabp.pharmacy/programs/vipps/.
5. Insurance billing transparency. If the platform bills your insurer directly, request an Explanation of Benefits (EOB) within 30 days to confirm accurate procedure and diagnosis codes.

Twenty-Eight Health currently satisfies some but not all of these criteria transparently. Patients should ask directly for any information not publicly posted.

Contraceptive Safety: The Clinical Evidence Base

Twenty-Eight Health's core product, combined oral contraceptives (COCs), has one of the most extensively studied safety profiles in pharmacology. Understanding that evidence helps patients separate product risk from platform risk.

Combined Oral Contraceptives: Efficacy Data

With perfect use, COCs have a failure rate of approximately 0.3% per year. With typical use, that figure rises to about 7% per year, per the CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 update (https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html).

Venous Thromboembolism Risk

COCs containing ethinyl estradiol carry a small but real venous thromboembolism (VTE) risk. The absolute risk in healthy, non-pregnant women of reproductive age is roughly 2 per 10,000 woman-years at baseline. COC use raises that to approximately 3 to 9 per 10,000 woman-years depending on progestin type, per a 2019 Danish cohort study (Vinogradova et al., BMJ 2019) that followed 1.65 million women (https://www.bmj.com/content/362/bmj.k4810). Appropriate screening for VTE risk factors (personal or family history of clotting disorders, smoking over age 35, immobility) is a standard part of any contraceptive intake form. Patients should confirm that Twenty-Eight Health's asynchronous intake questionnaire covers these contraindications explicitly.

The WHO Medical Eligibility Criteria

The World Health Organization's Medical Eligibility Criteria for Contraceptive Use (WHO MEC, 5th edition) is the global evidence standard for contraceptive prescribing (https://www.who.int/publications/i/item/9789241549158). The CDC adapted it for U.S. Practice. Any asynchronous telehealth intake that claims to replicate an in-person evaluation must capture the data categories listed in these criteria. Patients may ask Twenty-Eight Health directly which version of the MEC their intake protocol is based on.

Insurance Coverage and Billing Practices

Twenty-Eight Health accepts Medicaid in select states and a broad range of commercial insurance plans. This is a meaningful differentiator from most direct-to-consumer reproductive health platforms, which are cash-pay only.

The ACA Contraceptive Coverage Mandate

Under the Affordable Care Act, most private health plans must cover FDA-approved contraceptive methods with no cost-sharing for the patient (https://www.hhs.gov/healthcare/about-the-aca/index.html). That means many patients with employer-sponsored or marketplace insurance should pay $0 for COC prescriptions filled through a covered pharmacy. Whether Twenty-Eight Health's billing workflow correctly triggers this zero-cost benefit depends on the plan and the pharmacy used. Patients should request an itemized receipt and EOB to verify.

Medicaid Coverage Variation

Medicaid coverage for telehealth services varies by state. Some states require an initial in-person visit before covering telehealth follow-ups. Patients on Medicaid should confirm their state's current telehealth parity rules through their state Medicaid agency before assuming full coverage. The Kaiser Family Foundation maintains a regularly updated telehealth Medicaid policy tracker (https://www.kff.org).

Twenty-Eight Health Complaints: What Patients Report

Public complaint data on Twenty-Eight Health is limited. The BBB profile contains a small number of complaints, primarily about billing and prescription fulfillment delays, as of this writing. App store reviews (Apple App Store and Google Play) are the most granular public feedback source available.

Common Complaint Themes

Recurring themes in patient reviews include:

• Delays in prescription transmission to the pharmacy partner, sometimes exceeding 48 hours.
• Difficulty reaching customer support for billing disputes.
• Occasional insurance billing errors requiring patient intervention to resolve.

None of the publicly visible complaints, as of this review, allege prescribing errors, dangerous drug interactions missed during intake, or clinician impersonation. That is a meaningful clinical safety signal, though not a guarantee.

What the Absence of FDA Warning Letters Means

A search of the FDA's Warning Letter database (https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) returns no warning letters addressed to Twenty-Eight Health as of this review date. The FDA issues warning letters when it identifies specific violations. Their absence does not confirm full compliance, but it does mean no documented federal enforcement action has been taken.

How Twenty-Eight Health Compares to Regulatory Standards for Telehealth

The Federation of State Medical Boards published its Model Policy for the Appropriate Use of Telemedicine Technologies in the Practice of Medicine in 2014 and updated its telehealth guidance most recently in 2022 (https://www.fsmb.org/siteassets/advocacy/policies/fsmb_telemedicine_policy.pdf). That policy states: "The standard of care is not diminished simply because the patient and the physician are not in the same location."

That standard requires, at minimum, that a prescribing clinician collect sufficient history to identify contraindications, document the clinical rationale for prescribing, and establish a mechanism for follow-up. An asynchronous questionnaire can meet this standard if it is well-designed and reviewed by a licensed clinician before a prescription is issued.

Twenty-Eight Health uses an asynchronous intake model. Patients complete an online questionnaire; a licensed clinician reviews it and issues a prescription without a real-time video or phone visit. This is legal in most states for non-controlled substances. The clinical adequacy of the questionnaire content is the variable patients cannot easily assess from the outside.

The American College of Obstetricians and Gynecologists (ACOG) supports expanded contraceptive access through telehealth and pharmacy dispensing. ACOG Committee Opinion 788 states: "Hormonal contraception is safe for most healthy patients and can be provided without a routine pelvic examination" (https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/08/hormonal-contraception). That guidance supports the asynchronous model Twenty-Eight Health uses, provided contraindication screening is thorough.

What Patients Should Do Before Their First Prescription

Specific steps matter more than general reassurance.

Before You Submit the Intake Form

Read the contraindication screening questions carefully. If you have a personal or family history of deep vein thrombosis, pulmonary embolism, migraine with aura, hypertension, or active liver disease, those are WHO MEC Category 3 or 4 contraindications to combined oral contraceptives. The CDC's U.S. MEC lists these at https://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf. If the intake form does not ask about them, stop and use a different service or an in-person provider.

After Your Prescription Is Issued

Request the prescriber's full name, license number, and state of licensure. Verify that information against the appropriate state board database before filling the prescription. This takes under five minutes and is the single most important independent verification step a patient can take.

Ongoing Follow-Up

Blood pressure monitoring is recommended within the first three months of starting a COC. In a purely asynchronous model, that responsibility falls entirely on the patient. A home blood pressure cuff costs roughly $25 to $40 and is a reasonable investment for anyone starting hormonal contraception without an in-person provider relationship.